SEARCH RESULTS FOR: "Tag: PBYI"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(5)
2018(6)
2017(9)
2016(7)
2015(5)
2014(1)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(1)
Analyst Update(7)
Best and Worst Stocks(1)
Buzz Stocks(5)
By the Numbers(2)
Ezines(1)
General(2)
Indexes and ETFs(1)
Intraday Option Activity(3)
Midday Market Check(7)
Quantitative Analysis(2)
Stock Market News(2)
Stocks On the Move(4)
Technical Analysis(1)

10/8/2019 9:56 AM
Goldman Sachs downgraded Puma Biotechnology Inc (NASDAQ:PBYI) stock to "sell" from "neutral," and slashed its price target to $8 from $24 -- a 20.6% discount to last night's close. The brokerage firm...
9/5/2019 11:55 AM
The shares of Puma Biotechnology Inc (NASDAQ:PBYI) are enjoying a mini-rally today, up 3.1% to trade at $10.71 at last check. The drug stock has added 17% in the past month, but this has taken PBYI ri...
5/10/2019 11:55 AM
The Dow Jones Industrial Average (DJI) is down 300 points today following an increase in U.S. tariffs on Chinese goods and more tweeting this morning from President Donald Trump. Specifically, Pre...
4/1/2019 2:36 PM
The shares of Puma Biotechnology Inc (NASDAQ:PBYI) are down 9.3% to trade at $35.29, one of the worst stocks on the Nasdaq today, after the company inked an exclusive licensing deal with Pierre Fabre ...
3/1/2019 9:57 AM
The shares of Puma Biotechnology Inc (NASDAQ:PBYI) are up 40% at $39.10 in early trading, after the drugmaker announced better-than-expected revenue for the fourth quarter. The company also reported ...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center